Pharmacogenetics for Oncology Practice
- 15 August 2011
- journal article
- Published by Academy of Medicine, Singapore in Annals of the Academy of Medicine, Singapore
- Vol. 40 (8) , 348-349
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Crizotinib inALK-Rearranged Inflammatory Myofibroblastic TumorNew England Journal of Medicine, 2010
- Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate TranslationJNCI: Journal of the National Cancer Institute, 2010
- Inhibition of Mutated, Activated BRAF in Metastatic MelanomaNew England Journal of Medicine, 2010
- Genomewide Association Studies and Assessment of the Risk of DiseaseNew England Journal of Medicine, 2010
- Individualizing Dosing of IrinotecanClinical Cancer Research, 2010
- MGMTGene Silencing and Benefit from Temozolomide in GlioblastomaNew England Journal of Medicine, 2005
- Implications of Dihydropyrimidine Dehydrogenase on 5-Fluorouracil Pharmacogenetics and PharmacogenomicsPharmacogenomics, 2002
- Mercaptopurine Therapy Intolerance and Heterozygosity at the Thiopurine S-Methyltransferase Gene LocusJNCI: Journal of the National Cancer Institute, 1999